METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES

    公开(公告)号:SG11201708151TA

    公开(公告)日:2017-11-29

    申请号:SG11201708151T

    申请日:2016-04-22

    Abstract: The present invention provides method of increasing the percentage of monomer in a composition of recombinantly expressed antibody molecules characterised in that the antibody molecule comprises at least one Fv with specificity for an antigen of interest comprising one VH and one VL wherein said VH and VL are connected directly or indirectly via one or more linkers and are stabilised by a disulfide bond therebetween, said method comprises: a) a conversion step of treating the composition with a denaturant selected from urea and/or Guanidine hydrochloride; b) wherein step a) is performed in the presence of a reducing agent or after treatment with a reducing agent.

    Método para incrementar el porcentaje de anticuerpos monoméricos fab-dsfv de especies multiméricas

    公开(公告)号:CL2017002677A1

    公开(公告)日:2018-03-23

    申请号:CL2017002677

    申请日:2017-10-20

    Abstract: LA PRESENTE INVENCIÓN PROPORCIONA UN MÉTODO PARA AUMENTAR EL PORCENTAJE DE MONÓMERO EN UNA COMPOSICIÓN DE MOLÉCULAS DE ANTICUERPO EXPRESADAS RECOMBINAITEMENTE QUE SE CARACTERIZAN PORQUE LA MOLÉCULA DE ANTICUERPO COMPRENDE AL MENOS UN EV CON ESPECIFICIDAD PARA UN ANTÍGENO DE INTERÉS QUE COMPRENDE UNA VH Y UNA VL EN LA QUE DICHOS VH Y VL ESTÁN CONECTADOS DIRECTA O INDIRECTAMENTE A TRAVÉS DE UNO O MÁS ENLACES Y SE ESTABILIZAN MEDIANTE UN ENLACE DISULFURO ENTRE ELLOS, DICHO MÉTODO COMPRENDE: A) UNA ETAPA DE CONVERSIÓN TÉRMICA DE MANTENER LA COMPOSICIÓN QUE COMPRENDE LA MOLÉCULA DE ANTICUERPO A UNA TEMPERATURA EN EL INTERVALO DE 30 A 60 C DURANTE UN PERÍODO DE AL MENOS 1 HORA, EN EL QUE LA ETAPA A) SE REALIZA EN LA PRESENCIA DE UN AGENTE REDUCTOR O DESPUÉS DEL TRATAMIENTO CON UN AGENTE REDUCTOR.

    Method of monomerisation of recombinant antibody molecules

    公开(公告)号:AU2016251620A1

    公开(公告)日:2017-10-26

    申请号:AU2016251620

    申请日:2016-04-22

    Abstract: The present invention provides method of increasing the percentage of monomer in a composition of recombinantly expressed antibody molecules characterised in that the antibody molecule comprises at least one Fv with specificity for an antigen of interest comprising one VH and one VL wherein said VH and VL are connected directly or indirectly via one or more linkers and are stabilised by a disulfide bond therebetween, said method comprises: a) a conversion step of treating the composition with a denaturant selected from urea and/or Guanidine hydrochloride; b) wherein step a) is performed in the presence of a reducing agent or after treatment with a reducing agent.

    Método de monomerización de moléculas de anticuerpos recombinantes

    公开(公告)号:CO2017010385A2

    公开(公告)日:2018-03-20

    申请号:CO2017010385

    申请日:2017-10-11

    Abstract: La presente invención proporciona un método para aumentar el porcentaje de monómero en una composición de moléculas de anticuerpo expresadas de forma recombinante, caracterizado porque la molécula de anticuerpo comprende al menos un Fv con especificidad para un antígeno de interés que comprende un VH y un VL, en donde dichos VH y VL se conectan directa o indirectamente a través de uno o más enlazadores y se estabilizan mediante un enlace disulfuro entre ellos, dicho método comprende: a) una etapa de conversión para tratar la composición con un desnaturalizante seleccionado a partir de urea y/o clorhidrato de guanidina; b) en donde la etapa a) se lleva a cabo en presencia de un agente reductor o después del tratamiento con un agente reductor.

    METHOD FOR INCREASING THE PERCENTAGE OF MONOMERIC ANTIBODY FAB-DSFV MULTIMERIC SPECIES

    公开(公告)号:SG11201708430VA

    公开(公告)日:2017-11-29

    申请号:SG11201708430V

    申请日:2016-04-22

    Abstract: The present invention provides method for increasing the percentage of monomer in a composition of recombinantly expressed antibody molecules characterised in that the antibody molecule comprises at least one Fv with specificity for an antigen of interest comprising one VH and one VL wherein said VH and VL are connected directly or indirectly via one or more linkers and are stabilised by a disulfide bond therebetween, said method comprises a) a thermal conversion step of holding the composition comprising the antibody molecule at a temperature in the range 30 to 60° C. for a period of at least 1 hour, wherein step a) is performed in the presence of a reducing agent or after treatment with a reducing agent.

    Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric species

    公开(公告)号:AU2016251960A1

    公开(公告)日:2017-11-02

    申请号:AU2016251960

    申请日:2016-04-22

    Abstract: The present invention provides method for increasing the percentage of monomer in a composition of recombinantly expressed antibody molecules characterised in that the antibody molecule comprises at least one Fv with specificity for an antigen of interest comprising one VH and one VL wherein said VH and VL are connected directly or indirectly via one or more linkers and are stabilised by a disulfide bond therebetween, said method comprises: a)a thermal conversion stepof holding the composition comprising the antibody molecule at a temperature in the range 30 to 60°C for a period of at least 1 hour, wherein step a) is performed in the presence of a reducing agent or after treatment with a reducing agent.

    METHOD FOR INCREASING THE PERCENTAGE OF MONOMERIC ANTIBODY FAB-DSFV MULTIMERIC SPECIES

    公开(公告)号:CA2983537A1

    公开(公告)日:2016-10-27

    申请号:CA2983537

    申请日:2016-04-22

    Abstract: The present invention provides method for increasing the percentage of monomer in a composition of recombinantly expressed antibody molecules characterised in that the antibody molecule comprises at least one Fv with specificity for an antigen of interest comprising one VH and one VL wherein said VH and VL are connected directly or indirectly via one or more linkers and are stabilised by a disulfide bond therebetween, said method comprises: a)a thermal conversion stepof holding the composition comprising the antibody molecule at a temperature in the range 30 to 60°C for a period of at least 1 hour, wherein step a) is performed in the presence of a reducing agent or after treatment with a reducing agent.

Patent Agency Ranking